People: Amgen Inc (AMGN.O)

AMGN.O on Nasdaq

165.31USD
28 Nov 2014
Price Change (% chg)

$0.59 (+0.36%)
Prev Close
$164.72
Open
$165.00
Day's High
$167.35
Day's Low
$164.52
Volume
1,794,842
Avg. Vol
3,963,932
52-wk High
$167.35
52-wk Low
$108.20

Search Stocks

Harper, Sean 

Brief Biography

Dr. Sean E. Harper serves as Executive Vice President - Research and Development of Amgen Inc., since February 2012. Dr. Harper joined the Company in 2002 and has held leadership roles in early development, medical sciences and global regulatory and safety. Dr. Harper served as Senior Vice President, Global Development and Corporate Chief Medical Officer from March 2007 to February 2012. Prior to joining the Company, Dr. Harper worked for five years at Merck Research Laboratories.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
896,543 -- 1,766,230 5,862,670

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 8,000 447,070.00
Name Fiscal Year Total

Robert Bradway

5,650,890

David Meline

--

Madhavan Balachandran

5,768,710

Sean Harper

5,862,670

Anthony Hooper

6,179,500

Brian McNamee

--
As Of 30 Dec 2013
Search Stocks